Stryker's sales have grown about 10% a year on average over the past three years, and so have ResMed's. That shared growth rate in medical devices is the bet the two have in common. Stryker (SYK) is ...

ResMed currently trades at $218.94 per share and has shown little upside over the past six months, posting a small loss of ...

I look at what the next few years of earnings growth could mean for today’s valuation. The post Is the ResMed share price a ...

A deep-dive comparison of ResMed and Fisher & Paykel Healthcare shares: dividends, valuation, recent momentum, and which I ...

Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2027 on Thursday, October 29, 2026, after the New York Stock ...

Air Voel, a Canadian online CPAP retailer, highlights the importance of mask fit, seal and comfort in positive airway ...

ResMed Inc. stock closed at USD 225.35 on Nasdaq on September 18, 2026, about 6.7 percent below the USD 241.69 consensus target. A September 15, 2026 upgrade to Outperform with a raised USD 262 price ...

The Form 144 notice identifies Farrell as an officer and director and records the proposed sale through Fidelity Brokerage Services on the New York Stock Exchange. It also lists a cash-paid stock ...

COWZ, QUAL, and SPHQ each aim to put you in higher-quality companies, but their portfolios barely recognize each other.

Farrell exercised 4,991 ResMed common stock options at an exercise price of $146.34 per share on October 7, 2026. Share Sale: The identical 4,991 ...